Convatec Group PLC

Declaration of Voting Results & Voting Rights Announcements • May 7, 2020

National Storage Mechanism | Additional information

RNS Number : 3272M

ConvaTec Group PLC

07 May 2020

ConvaTec Group Plc

Results of Annual General Meeting

Reading, United Kingdom 7 May 2020 - Poll Result

ConvaTec Group Plc ("ConvaTec"), a leading global medical products and technologies company, held its annual general meeting today ("Meeting"), The results of the poll held in relation to the resolutions proposed at the Meeting are set out below.

		For (see note 2)		Against (see note 2)		Total Votes	% of ISC Voted	Number of Votes Withheld (see note 3
Resolution		No of shares	%	No of Shares	%
1	Receive Annual Report and Accounts	1,689,253,478	99.99	162,424	0.01	1,689,415,902	85.17	1,375,861
2	Approve the Directors' Remuneration Report	1,459,271,427	86.35	230,658,135	13.65	1,689,929,562	85.20	908,684
3	Approve the Directors' Remuneration Policy	1,479,320,219	87.54	210,611,343	12.46	1,689,931,562	85.20	906,684
4	Declare Final Dividend	1,670,311,992	98.79	20,526,249	1.21	1,690,838,241	85.24	6
5	Elect John McAdam as a director	1,686,038,868	99.72	4,725,844	0.28	1,690,764,712	85.24	73,534
6	Elect Karim Bitar as a director	1,687,089,831	99.78	3,746,388	0.22	1,690,836,219	85.24	2,028
7	Elect Brian May as a director	1,689,080,374	99.90	1,749,450	0.10	1,690,829,824	85.24	8,423
8	Re-elect Frank Schulkes as a director	1,684,095,328	99.60	6,734,291	0.40	1,690,829,619	85.24	8,628
9	Re-elect Margaret Ewing as a director	1,662,219,417	98.31	28,611,702	1.69	1,690,831,119	85.24	7,128
10	Re-elect Rick Anderson as a director	1,686,272,799	99.73	4,561,920	0.27	1,690,834,719	85.24	3,528
11	Re-elect Regina Benjamin as a director	1,678,521,751	99.30	11,891,727	0.70	1,690,413,478	85.22	424,768
12	Re-elect Ros Rivaz as a director	1,630,402,633	96.47	59,672,747	3.53	1,690,075,380	85.21	762,866
13	Re-elect Sten Scheibye as a director	1,687,084,151	99.78	3,745,468	0.22	1,690,829,619	85.24	8,628
14	Re-appoint Deloitte LLP as auditor	1,690,827,240	100.00	9,746	0.00	1,690,836,986	85.24	1,261
15	Authorise the directors to determine the remuneration of the Company's auditor	1,690,692,456	100.00	5,000	0.00	1,690,697,456	85.24	140,791
16	Authorise political donations and political expenditure	1,679,778,558	99.35	11,050,957	0.65	1,690,829,515	85.24	8,732
17	Authorise allotment of shares	1,576,731,448	93.28	113,598,212	6.72	1,690,329,660	85.22	508,587
18	Disapply pre-emption rights*	1,665,615,258	98.53	24,844,432	1.47	1,690,459,690	85.23	378,557
19	Disapply pre-emption rights in connection with an acquisition or specified capital investment*	1,664,010,440	98.44	26,449,249	1.56	1,690,459,689	85.23	378,557
20	Authorise purchase of own shares*	1,669,151,425	98.76	20,937,729	1.24	1,690,089,154	85.21	749,092
21	Call general meetings on 14 days' notice*	1,663,148,185	98.36	27,687,156	1.64	1,690,835,341	85.24	2,906

*Special Resolution

NOTES:

1.   All resolutions were passed.

2.   Votes "For" and "Against" are expressed as a percentage of votes received.

3.   A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

4.   Total number of shares in issue at close of business on 6 May 2020 was 1,983,513,851 shares; 85.24% of voting capital was instructed.

5.   Computershare acted as scrutineer of the poll on all resolutions.

In accordance with Listing Rule 9.6.2, copies of the resolutions that do not constitute ordinary business that were passed at the Meeting will be submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.

Enquiries

Analysts and Investors

Mark Reynolds, Director Investor Relations, ConvaTec            +44 (0)7551 036 625

ir@convatec.com

Media

Buchanan: Charles Ryland / Chris Lane / Vicky Hayns             +44 (0)207 466 5000                                                                                                          

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

# # #

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RAGUBAVRRRUVRAR